{
    "2018-11-05": [
        [
            {
                "time": "",
                "original_text": "医药生物行业2018年三季报综述——行业整体收入和扣非利润保持20%的增速中枢",
                "features": {
                    "keywords": [
                        "医药生物",
                        "三季报",
                        "收入",
                        "扣非利润",
                        "增速"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "一周机构去哪儿？汇丰银行、千合资本等调研了这些个股（名单）",
                "features": {
                    "keywords": [
                        "机构调研",
                        "汇丰银行",
                        "千合资本",
                        "个股"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "机构调研再升温 聚焦生物医药行业",
                "features": {
                    "keywords": [
                        "机构调研",
                        "生物医药",
                        "升温"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "上周机构调研123家公司数量飙升近四成，20只潜力股备受外资青睐",
                "features": {
                    "keywords": [
                        "机构调研",
                        "公司数量",
                        "飙升",
                        "外资",
                        "潜力股"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "161只个股连涨5天及以上 四大特征彰显强势逻辑",
                "features": {
                    "keywords": [
                        "个股",
                        "连涨",
                        "强势逻辑"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "上周机构调研123家公司数量飙升近4成 20股受外资青睐",
                "features": {
                    "keywords": [
                        "机构调研",
                        "公司数量",
                        "飙升",
                        "外资"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医疗服务深度解读系列之一:体检渠道下沉,把握蓝海市场红利",
                "features": {
                    "keywords": [
                        "医疗服务",
                        "体检",
                        "渠道下沉",
                        "蓝海市场",
                        "红利"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗服务"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}